Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
21.4%
% of WDNA's 90 holdings also in FBT
60.0%
% of FBT's 31 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 3.7% | 3.3% | 3.3% |
|
VERACYTE INC | 2.1% | 3.3% | 2.1% |
|
GILEAD SCIENCES INC | 1.9% | 3.4% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% | 3.4% | 1.8% |
|
UNITED THERAPEUTICS CORP | 1.7% | 3.4% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to FBT
|
TWIST BIOSCIENCE CORP. | 3.3% |
 |
NOVOZYMES A/S-B SHARES | 2.9% |
|
ELI LILLY & CO | 2.7% |
|
BLUEPRINT MEDICINES CORP. | 2.6% |
|
VERICEL CORPORATION | 2.6% |
|
BRIDGEBIO PHARMA, INC. | 2.4% |
|
AGIOS PHARMACEUTICALS INC | 1.9% |
 |
NOVARTIS AG | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.5% |
|
LABCORP HOLDINGS | 1.5% |
WDNA Underweight Relative to FBT
|
NEUROCRINE BIOSCIENCES INC | -3.7% |
|
EXELIXIS INC | -3.4% |
|
INCYTE CORP | -3.4% |
|
KRYSTAL BIOTECH, INC. | -3.4% |
|
ACADIA PHARMACEUTICALS INC | -3.4% |
|
BEIGENE LTD. SPONSORED ADR | -3.3% |
 |
ALKERMES PLC | -3.3% |
|
WATERS CORP | -3.3% |
|
HALOZYME THERAPEUTICS INC | -3.2% |
|
METTLER-TOLEDO INTERNATIONAL | -3.2% |